Health Canada concludes from a recent safety review that hepatotoxicity remains an important safety concern for patients using antiandrogens.

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1423, 2012-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No safety concerns with Rotarix concludes EMA

By  

Reactions Weekly, Vol. 1, Iss. 1295-1296, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Info on paediatric drug safety released by Health Canada

By  

Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Health Canada issues safety update for tinzaparin sodium

By  

Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Acetaminophen safety and hepatotoxicity – where do we go from here?

By Amar Patrick J   Schiff Eugene R  

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 341-355

Informa Healthcare

Access to resources Recommend Favorite

Safety and Tolerability of Agomelatine: Focus on Hepatotoxicity

By  

Current Drug Metabolism, Vol. 15, Iss. 7, 2014-09 ,pp. : 694-702

Bentham Science Publishers

Access to resources Recommend Favorite